title: [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
abstract: Diagnostic value of prostate specific antigen (PSA) was studied in 163 patients with prostatic hyperplasia. As PSA is not a cancer-specific test, it is recommended to obtain biopsy in patients with prostatic hyperplasia and PSA > 4 ng/ml to diagnose prostatic cancer early. Methods raising PSA specificity for differential diagnosis of prostatic hyperplasia are not absolutely reliable.
authors.forename: V A
authors.initials: VA
authors.lastname: Maksimov
authors.forename: A A
authors.initials: AA
authors.lastname: Kamalov
authors.forename: V K
authors.initials: VK
authors.lastname: Karpov
authors.forename: A V
authors.initials: AV
authors.lastname: Riaboĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Prokhorov
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology
chemical_list: D017430:Prostate-Specific Antigen